BriaCell Therapeutics

BCTXL · NASDAQ

$0.8899−$0.0126 (−1.40%)TodayMarket closed ·
Prev close $0.9025

BCTXL key statistics

Market cap
—
Price-earnings ratio
0.00
Dividend yield
—
Average volume
18.45K
Volume
11.58K
Open price
$0.89
High today
$0.90
Low today
$0.885
52 Week high
$1.40
52 Week low
$0.61

BriaCell Therapeutics (BCTXL) at a glance

BriaCell Therapeutics (BCTXL) last traded at $0.8899, with a price-to-earnings ratio of 0.00.

Today the stock has traded between $0.885 and $0.90. The current price is 0.6% above the day's low and 1.1% below its high.

Volume so far is 11.58K shares, below the average of 18.45K shares a day.

Over the past year BriaCell Therapeutics has ranged from $0.61 to $1.40, and now sits 35% of the way up that range.

BCTXL news

  • Press releaseGlobe Newswire

    BriaCell’s Pivotal Phase 3 Metastatic Breast Cancer Study Expands to Leading Cancer Center

  • Press releaseGlobe Newswire

    BriaCell Opens First Canadian Site – Sunnybrook – for Pivotal Phase 3 Trial in Metastatic Breast Cancer

  • Press releaseGlobe Newswire

    BriaCell and BriaPro Announce Closing of Asset Purchase Transaction for Exclusive Soluble CD80 License

  • Press releaseGlobe Newswire

    BriaCell and BriaPro Enter Into Asset Purchase Agreement for Exclusive Soluble CD80 License

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.